Tandem Diabetes Care Inc

TNDM: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
NbkLOCK|x&LOCK|vhY<&H@

Tandem Earnings: Few Surprises as the Firm Makes Progress With Mobi Pump

Tandem Diabetes posted second-quarter revenue growth of 6% and approximately halved its negative earnings year over year. Management maintained its outlook, and shares barely bobbled.

Sponsor Center